Summary: In 2018, over 40% of new clinical studies had sites in the APAC region this trend is expected to continue to grow in the coming years.

Summary: Catalent and Fierce Pharma surveyed 234 individuals involved in clinical supply and clinical operations to better understand the industry perception around importance of having a direct-to-patient option...

Summary: Overcoming complex blinding and masking challenges in clinical trials requires a balance of strategy and adaptability. When conducting clinical trials...

Summary: With the growth in semi and fully remote clinical studies, the ability to offer direct-to-patient distribution of clinical supplies is becoming increasingly important for clinical...

Summary: With an increasing number of clinical studies being conducted in the Asia-Pacific (APAC) region, there is a growing need for streamlining import and export strategies...

Summary: Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel...

Summary: Most commercial contract drug packagers do not provide consistent scheduling for low-volume drugs, which creates supply challenges. In fact, a drug packaging delay can create a market shortage that triggers...

Summary: Free trade zones offer many advantages for our customers interested in clinical trial supply. The zone provides fast, safe and secure transit to controlled storage situation which can delay or...

Summary: Covering virtually all dosage forms, we provide a comprehensive, full-service, and vertically integrated operation for clinical trial materials preparation in support of Phase I through...

Summary: With more than 70 years of sterile manufacturing experience with injectables and a global infrastructure of cGMP and FDA-compliant facilities, we have the expertise, processes...